Hepatitis C virus inhibitors
US8093243B2 · kind B2 · utility
2Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2009 |
| Grant date | Jan 10, 2012 |
| Priority date | — |
| Expiry date | Aug 22, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.